Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Evaluation of eligibility and recruitment in breast cancer clinical trials.

Lemieux J, Forget G, Brochu O, Provencher L, Cantin G, Desbiens C, Doyle C, Poirier B, Camden S, Durocher M.

Breast. 2014 Aug;23(4):385-92. doi: 10.1016/j.breast.2014.02.002. Epub 2014 Mar 26.

2.

Adoption of American Heart Association 2020 ideal healthy diet recommendations prevents weight gain in young adults.

Forget G, Doyon M, Lacerte G, Labonté M, Brown C, Carpentier AC, Langlois MF, Hivert MF.

J Acad Nutr Diet. 2013 Nov;113(11):1517-22. doi: 10.1016/j.jand.2013.06.346. Epub 2013 Aug 27.

PMID:
23988512
3.

Eligibility criteria in randomized phase II and III adjuvant and neoadjuvant breast cancer trials: not a significant barrier to enrollment.

Filion M, Forget G, Brochu O, Provencher L, Desbiens C, Doyle C, Poirier B, DuRocher M, Camden S, Lemieux J.

Clin Trials. 2012 Oct;9(5):652-9. doi: 10.1177/1740774512456453.

PMID:
23060323
4.

Picosecond acoustics in vegetal cells: non-invasive in vitro measurements at a sub-cell scale.

Audoin B, Rossignol C, Chigarev N, Ducousso M, Forget G, Guillemot F, Durrieu MC.

Ultrasonics. 2010 Feb;50(2):202-7. doi: 10.1016/j.ultras.2009.09.019. Epub 2009 Sep 27.

PMID:
19879618
5.

[The role of the family: outlook for personal and collective mechanisms for promoting the health of young people].

Forget G.

Cien Saude Colet. 2007 Sep-Oct;12(5):1121-3. French. No abstract available.

6.

A novel form of NF-kappaB is induced by Leishmania infection: involvement in macrophage gene expression.

Gregory DJ, Godbout M, Contreras I, Forget G, Olivier M.

Eur J Immunol. 2008 Apr;38(4):1071-81. doi: 10.1002/eji.200737586.

7.

RGD nanodomains grafting onto titanium surface.

Forget G, Latxague L, Héroguez V, Labrugère C, Durrieu MC.

Conf Proc IEEE Eng Med Biol Soc. 2007;2007:5107-10.

PMID:
18003155
8.
9.

Proteasome-mediated degradation of STAT1alpha following infection of macrophages with Leishmania donovani.

Forget G, Gregory DJ, Olivier M.

J Biol Chem. 2005 Aug 26;280(34):30542-9. Epub 2005 Jun 27.

10.

Regulation of the Leishmania-induced innate inflammatory response by the protein tyrosine phosphatase SHP-1.

Forget G, Matte C, Siminovitch KA, Rivest S, Pouliot P, Olivier M.

Eur J Immunol. 2005 Jun;35(6):1906-17.

11.

Subversion mechanisms by which Leishmania parasites can escape the host immune response: a signaling point of view.

Olivier M, Gregory DJ, Forget G.

Clin Microbiol Rev. 2005 Apr;18(2):293-305. Review.

12.

Role of host phosphotyrosine phosphatase SHP-1 in the development of murine leishmaniasis.

Forget G, Siminovitch KA, Brochu S, Rivest S, Radzioch D, Olivier M.

Eur J Immunol. 2001 Nov;31(11):3185-96.

13.

An ecosystem approach to human health.

Forget G, Lebel J.

Int J Occup Environ Health. 2001 Apr-Jun;7(2 Suppl):S3-38. Review. No abstract available.

PMID:
11387989
14.

Managing the ecosystem to improve human health: integrated approaches to safe drinking water.

Forget G, Sanchez-Bain WA.

Int J Occup Environ Health. 1999 Jan-Mar;5(1):38-50. Review.

PMID:
10092746
15.

The Impact of upport of Occupational Health Research on National Development in Developing Countries.

Rutherford BA, Forget G.

Int J Occup Environ Health. 1997 Jan;3(1):68-83.

PMID:
9891103
16.

[Evaluation of the effectiveness of a program for prevention of pregnancy in adolescence: speak up for responsible sexuality].

Bilodeau A, Forget G, Tétreault J.

Can J Commun Ment Health. 1994 Fall;13(2):163-81. French. No abstract available.

PMID:
10150328
17.

[Contraceptive self efficacy in male and female adolescents: validation of the French version of the Levinson scale].

Bilodeau A, Forget G, Tétreault J.

Can J Public Health. 1994 Mar-Apr;85(2):115-20. French.

PMID:
8012913
18.

Ongoing research in occupational health and environmental epidemiology in developing countries.

Levy BS, Kjellstrom T, Forget G, Jones MR, Pollier L.

Arch Environ Health. 1992 May-Jun;47(3):231-5.

PMID:
1596107
19.
20.

Pesticides and the Third World.

Forget G.

J Toxicol Environ Health. 1991 Jan;32(1):11-31.

PMID:
1987360
21.

Results of neoadjuvant chemotherapy and radiation therapy in the breast-conserving treatment of 250 patients with all stages of infiltrative breast cancer.

Jacquillat C, Weil M, Baillet F, Borel C, Auclerc G, de Maublanc MA, Housset M, Forget G, Thill L, Soubrane C, et al.

Cancer. 1990 Jul 1;66(1):119-29.

PMID:
2112976
22.

[Expectations and defeat in the treatment of epithelial cancer of the ovary].

Weil M, Borel C, Auclerc G, Forget G, Durandin-Truffinet M, Thill L, Khayat D, Jacquillat C.

Ann Med Interne (Paris). 1990;141(1):15-9. French.

PMID:
2321883
23.

Response of perifused alveolar macrophages to glass fibers: effect of exposure duration and fiber length.

Forget G, Lacroix MJ, Brown RC, Evans PH, Sirois P.

Environ Res. 1986 Feb;39(1):124-35.

PMID:
3943503
24.
25.

An adherent cell perifusion technique to study the overall and sequential response of rat alveolar macrophages to toxic substances.

Forget G, Lacroix MJ, Cadieux A, Calvert R, Grose JH, Sirois P.

Environ Health Perspect. 1983 Sep;51:131-40.

26.
27.

Lack of correlation between serum angiotensin-converting enzyme levels and asbestosis in man, sheep and guinea-pig.

Forget G, Brault C, Cadieux A, Bégin R, Sirois P.

Lung. 1983;161(3):157-64. No abstract available.

PMID:
6308362
28.

Tympanic membrane rupture after anesthesia with nitrous oxide.

Perreault L, Normandin N, Plamondon L, Blain R, Rousseau P, Girard M, Forget G.

Anesthesiology. 1982 Oct;57(4):325-6. No abstract available.

PMID:
7125271
29.

Middle ear pressure variations during nitrous oxide and oxygen anaesthesia.

Perreault L, Normandin N, Plamondon L, Blain R, Rousseau P, Girard M, Forget G.

Can Anaesth Soc J. 1982 Sep;29(5):428-34.

PMID:
7127176
30.

[Gas diffusion in the middle ear during anesthesia for tympanoplasty].

Perreault L, Rousseau P, Garneau JF, Forget G.

Can Anaesth Soc J. 1981 Mar;28(2):136-10. French.

PMID:
7248824
31.

Enzymatic modifications of bovine adrenocortical angiotensin II receptors.

Forget G, Heisler S.

Can J Physiol Pharmacol. 1979 Oct;57(10):1067-72.

PMID:
228826
32.

[Sialoscintimetry in disorders of the facial nerve].

Marsan JG, Forget G, Levasseur A.

J Otolaryngol. 1979 Apr;8(2):138-44. French.

PMID:
430580
33.
34.

Preparation and characterization of adrenocortical plasma membrane angiotensin II receptors.

Forget G, Heisler S.

Can J Physiol Pharmacol. 1976 Oct;54(5):698-707.

PMID:
186167
35.

Calcium-activated ATPase activity in a plasma membrane-rich preparation of rat pancreas.

Forget G, Heisler S.

Clin Exp Pharmacol Physiol. 1976 Jan-Feb;3(1):67-72.

PMID:
183927
36.

Characterization of an angiotensin II-fluorescamine derivative.

Forget G, Heisler S, Park WK, Sirois P, Gagnon D, Regoli D.

J Pharm Pharmacol. 1975 Jul;27(7):491-6.

PMID:
239153
37.

The effect of various secretagogues on accumulation of cyclic AMP and secretion of alpha-amylase from rat exocrine pancreas.

Heisler S, Grondin G, Forget G.

Life Sci. 1974 Feb 16;14(4):631-9. No abstract available.

PMID:
4363006
38.

["Malignant" papillomatosis of the respiratory tract].

Lamarche J, Forget G, Thibert D, Auger C.

Union Med Can. 1973 Aug;103(8):1687-90. French. No abstract available.

PMID:
4151994
39.

[Fractures of the zygoma].

Forget G, Belanger C.

Can J Otolaryngol. 1973;2(3):254-8. French. No abstract available.

PMID:
4791586
40.

[The diagnosis and ego function of child encopretics].

Gauthier Y, Drapeau P, Leclaire F, Fortin C, Forget G.

Can Psychiatr Assoc J. 1970 Jun;15(3):265-77. French. No abstract available.

PMID:
4193561

Supplemental Content

Loading ...
Support Center